PAVmed
PAVM
97 hedge funds and large institutions have $134M invested in PAVmed in 2021 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 19 closing their positions.
67% more capital invested
Capital invested by funds: $80.7M → $134M (+$53.8M)
57% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 21
54% more call options, than puts
Call options by funds: $1.83M | Put options by funds: $1.19M
37% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 19
7% more funds holding
Funds holding: 91 → 97 (+6)
0.01% more ownership
Funds ownership: 0.05% → 0.06% (+0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
N
Nuveen
Charlotte,
North Carolina
|
+$5.3M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$4.18M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.01M |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$1.97M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MWNA
Marshall Wace North America
New York
|
-$2.33M |
| 2 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$1.94M |
| 3 |
Millennium Management
New York
|
-$1.71M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$806K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
-$702K |
PAVM Hedge Fund Activity: Q2 2021 in Review
97 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2021, worth a combined $134M — up 67% from $80.7M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new PAVM positions and 19 closed out — a net gain of 7 holders — while 33 added to existing stakes and 21 trimmed.
The largest buyer was Nuveen, adding an estimated $5.3M. The largest seller was Marshall Wace North America, cutting an estimated $2.33M.
- 97 institutional investors held PAVmed (PAVM) as of Q2 2021, up from 91 in Q1 2021.
- Funds reported $134M of PAVmed stock for Q2 2021, up 67% quarter-over-quarter.
- 26 funds opened new PAVmed positions in Q2 2021 and 19 closed out, a net change of +7 holders.
- The largest PAVmed buyer in Q2 2021 was Nuveen, an estimated $5.3M added.
- The largest PAVmed seller in Q2 2021 was Marshall Wace North America, an estimated $2.33M sold.
Based on aggregated 13F filings for Q2 2021.